CTKB
Cytek Biosciences, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$6.15
−2.38%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 3.60x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 2.48x
- Price / sales
- 3.87x
- Price / cash flow
- -132.39x
Enterprise value
- Enterprise value
- $563.9M
- EV / sales
- 2.73x
- EV / EBITDA
- -20.77x
- EV / EBIT
- -12.63x
- Market cap
- $799.4M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026